Characteristics of smoking patients with lung cancer with emphysematous bullae

Eiji Iwama, Isamu Okamoto, Hidetake Yabuuchi, Koichi Takayama, Taishi Harada, Yoshio Matsuo, Shoji Tokunaga, Eishi Baba, Yoichi Nakanishi

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

抄録

Introduction: Emphysema is thought to be a risk factor for lung cancer in smokers, with emphysematous bullae (EBs), which are believed to have the potential to give rise to lung cancer. The clinical characteristics of patients with lung cancer with EBs have remained incompletely defined, however. Methods: A total of 488 patients with primary lung cancer with or without EBs as detected by computed tomography were studied retrospectively, and the regional relationship between EBs and the primary cancer was evaluated. Results: EBs were detected in 45 of the 488 patients with lung cancer (9.2%) (in 45 of 339 smokers [13.3%] versus in 0 of 149 never-smokers [0%]). The frequency of lung cancer in an upper lobe was significantly higher in smokers with EBs than in those without EBs (71.1% versus 47.3%, p = 0.0107). The lobar site of primary lung cancer in smokers with EBs was significantly associated with that of the EBs (p < 0.0001). Most primary lung cancers (86.7%) in such patients were found in the area adjoining EBs. Smoking patients with lung cancer with EBs were significantly younger (63.6 versus 67.7 years, p = 0.0179) and had tumors with a lower frequency of epidermal growth factor gene (EGFR) mutations (3.8% versus 24.2%, p = 0.0184) compared with those without EBs. Conclusions: The clinical characteristics of smoking patients with lung cancer differ according to the absence or presence of EBs, with patients with EBs being potentially more susceptible to the carcinogenic effects of cigarette smoke. Further analysis of genetic alterations is warranted to elucidate the mechanism of carcinogenesis for lung cancer associated with EBs.

元の言語英語
ページ(範囲)1586-1590
ページ数5
ジャーナルJournal of Thoracic Oncology
11
発行部数9
DOI
出版物ステータス出版済み - 1 1 2016

Fingerprint

Blister
Lung Neoplasms
Smoking
Emphysema
Epidermal Growth Factor
Smoke
Tobacco Products
Neoplasms
Carcinogenesis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine

これを引用

Characteristics of smoking patients with lung cancer with emphysematous bullae. / Iwama, Eiji; Okamoto, Isamu; Yabuuchi, Hidetake; Takayama, Koichi; Harada, Taishi; Matsuo, Yoshio; Tokunaga, Shoji; Baba, Eishi; Nakanishi, Yoichi.

:: Journal of Thoracic Oncology, 巻 11, 番号 9, 01.01.2016, p. 1586-1590.

研究成果: ジャーナルへの寄稿記事

Iwama, Eiji ; Okamoto, Isamu ; Yabuuchi, Hidetake ; Takayama, Koichi ; Harada, Taishi ; Matsuo, Yoshio ; Tokunaga, Shoji ; Baba, Eishi ; Nakanishi, Yoichi. / Characteristics of smoking patients with lung cancer with emphysematous bullae. :: Journal of Thoracic Oncology. 2016 ; 巻 11, 番号 9. pp. 1586-1590.
@article{66e561d7a63a4e988b2889036d316910,
title = "Characteristics of smoking patients with lung cancer with emphysematous bullae",
abstract = "Introduction: Emphysema is thought to be a risk factor for lung cancer in smokers, with emphysematous bullae (EBs), which are believed to have the potential to give rise to lung cancer. The clinical characteristics of patients with lung cancer with EBs have remained incompletely defined, however. Methods: A total of 488 patients with primary lung cancer with or without EBs as detected by computed tomography were studied retrospectively, and the regional relationship between EBs and the primary cancer was evaluated. Results: EBs were detected in 45 of the 488 patients with lung cancer (9.2{\%}) (in 45 of 339 smokers [13.3{\%}] versus in 0 of 149 never-smokers [0{\%}]). The frequency of lung cancer in an upper lobe was significantly higher in smokers with EBs than in those without EBs (71.1{\%} versus 47.3{\%}, p = 0.0107). The lobar site of primary lung cancer in smokers with EBs was significantly associated with that of the EBs (p < 0.0001). Most primary lung cancers (86.7{\%}) in such patients were found in the area adjoining EBs. Smoking patients with lung cancer with EBs were significantly younger (63.6 versus 67.7 years, p = 0.0179) and had tumors with a lower frequency of epidermal growth factor gene (EGFR) mutations (3.8{\%} versus 24.2{\%}, p = 0.0184) compared with those without EBs. Conclusions: The clinical characteristics of smoking patients with lung cancer differ according to the absence or presence of EBs, with patients with EBs being potentially more susceptible to the carcinogenic effects of cigarette smoke. Further analysis of genetic alterations is warranted to elucidate the mechanism of carcinogenesis for lung cancer associated with EBs.",
author = "Eiji Iwama and Isamu Okamoto and Hidetake Yabuuchi and Koichi Takayama and Taishi Harada and Yoshio Matsuo and Shoji Tokunaga and Eishi Baba and Yoichi Nakanishi",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.jtho.2016.04.024",
language = "English",
volume = "11",
pages = "1586--1590",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "9",

}

TY - JOUR

T1 - Characteristics of smoking patients with lung cancer with emphysematous bullae

AU - Iwama, Eiji

AU - Okamoto, Isamu

AU - Yabuuchi, Hidetake

AU - Takayama, Koichi

AU - Harada, Taishi

AU - Matsuo, Yoshio

AU - Tokunaga, Shoji

AU - Baba, Eishi

AU - Nakanishi, Yoichi

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Introduction: Emphysema is thought to be a risk factor for lung cancer in smokers, with emphysematous bullae (EBs), which are believed to have the potential to give rise to lung cancer. The clinical characteristics of patients with lung cancer with EBs have remained incompletely defined, however. Methods: A total of 488 patients with primary lung cancer with or without EBs as detected by computed tomography were studied retrospectively, and the regional relationship between EBs and the primary cancer was evaluated. Results: EBs were detected in 45 of the 488 patients with lung cancer (9.2%) (in 45 of 339 smokers [13.3%] versus in 0 of 149 never-smokers [0%]). The frequency of lung cancer in an upper lobe was significantly higher in smokers with EBs than in those without EBs (71.1% versus 47.3%, p = 0.0107). The lobar site of primary lung cancer in smokers with EBs was significantly associated with that of the EBs (p < 0.0001). Most primary lung cancers (86.7%) in such patients were found in the area adjoining EBs. Smoking patients with lung cancer with EBs were significantly younger (63.6 versus 67.7 years, p = 0.0179) and had tumors with a lower frequency of epidermal growth factor gene (EGFR) mutations (3.8% versus 24.2%, p = 0.0184) compared with those without EBs. Conclusions: The clinical characteristics of smoking patients with lung cancer differ according to the absence or presence of EBs, with patients with EBs being potentially more susceptible to the carcinogenic effects of cigarette smoke. Further analysis of genetic alterations is warranted to elucidate the mechanism of carcinogenesis for lung cancer associated with EBs.

AB - Introduction: Emphysema is thought to be a risk factor for lung cancer in smokers, with emphysematous bullae (EBs), which are believed to have the potential to give rise to lung cancer. The clinical characteristics of patients with lung cancer with EBs have remained incompletely defined, however. Methods: A total of 488 patients with primary lung cancer with or without EBs as detected by computed tomography were studied retrospectively, and the regional relationship between EBs and the primary cancer was evaluated. Results: EBs were detected in 45 of the 488 patients with lung cancer (9.2%) (in 45 of 339 smokers [13.3%] versus in 0 of 149 never-smokers [0%]). The frequency of lung cancer in an upper lobe was significantly higher in smokers with EBs than in those without EBs (71.1% versus 47.3%, p = 0.0107). The lobar site of primary lung cancer in smokers with EBs was significantly associated with that of the EBs (p < 0.0001). Most primary lung cancers (86.7%) in such patients were found in the area adjoining EBs. Smoking patients with lung cancer with EBs were significantly younger (63.6 versus 67.7 years, p = 0.0179) and had tumors with a lower frequency of epidermal growth factor gene (EGFR) mutations (3.8% versus 24.2%, p = 0.0184) compared with those without EBs. Conclusions: The clinical characteristics of smoking patients with lung cancer differ according to the absence or presence of EBs, with patients with EBs being potentially more susceptible to the carcinogenic effects of cigarette smoke. Further analysis of genetic alterations is warranted to elucidate the mechanism of carcinogenesis for lung cancer associated with EBs.

UR - http://www.scopus.com/inward/record.url?scp=84987849979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987849979&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2016.04.024

DO - 10.1016/j.jtho.2016.04.024

M3 - Article

C2 - 27164304

AN - SCOPUS:84987849979

VL - 11

SP - 1586

EP - 1590

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 9

ER -